Evidence map›Paper›PMID 28893903›Full record

ArticleThe Journal of biological chemistry2017

Estrogen receptor β-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor α (TNFα)-induced apoptosis.

Francesca Fortini, Francesco Vieceli Dalla Sega, Cristiana Caliceti, Giorgio Aquila, Micaela Pannella, Antonio Pannuti, Lucio Miele, Roberto Ferrari, Paola Rizzo

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Kindlin-2 controls angiogenesis through modulating Notch1 signaling.Cellular and molecular life sciences : CMLS · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Francesca FortiniFrom the Departments of Medical Sciences and.
Francesco Vieceli Dalla SegaFrom the Departments of Medical Sciences and.
Cristiana Calicetithe Department of Chemistry "G. Ciamician" and Interdepartmental Centre for Industrial Research in Energy and Environment (CIRI EA), University of Bologna, 40126 Bologna, Italy.
Giorgio AquilaFrom the Departments of Medical Sciences and.
Micaela Pannellathe Interdepartmental Center for Industrial Research and Life Sciences (CIRI-SDV), Foundation IRET, University of Bologna, 40064 Ozzano Emilia (BO), Italy.
Antonio Pannutithe Stanley Scott Cancer Center, Louisiana State University Health Sciences Center and Louisiana Cancer Research Consortium, New Orleans, Louisiana 70112.
Lucio Mielethe Stanley Scott Cancer Center, Louisiana State University Health Sciences Center and Louisiana Cancer Research Consortium, New Orleans, Louisiana 70112.
Roberto FerrariFrom the Departments of Medical Sciences and.
Paola Rizzothe Maria Cecilia Hospital, GVM Care and Research, E.S. Health Science Foundation, 48033 Cotignola, Italy, and rzzpla@unife.it.
Louisiana State University · USUniversity of Ferrara · ITCentre International de Recherche en Infectiologie · FRIstituto Nazionale Biostrutture e Biosistemi · IT

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI JUDD E SHELLITO · 2012 to 2026
$69.1M
NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

Unlike age-matched men, premenopausal women benefit from cardiovascular protection. Estrogens protect against apoptosis of endothelial cells (ECs), one of the hallmarks of endothelial dysfunction leading to cardiovascular disorders, but the underlying molecular mechanisms remain poorly understood. The inflammatory cytokine TNFα causes EC apoptosis while dysregulating the Notch pathway, a major contributor to EC survival. We have previously reported that 17β-estradiol (E2) treatment activates Notch signaling in ECs. Here, we sought to assess whether in TNFα-induced inflammation Notch is involved in E2-mediated protection of the endothelium. We treated human umbilical vein endothelial cells (HUVECs) with E2, TNFα, or both and found that E2 counteracts TNFα-induced apoptosis. When Notch1 was inhibited, this E2-mediated protection was not observed, whereas ectopic overexpression of Notch1 diminished TNFα-induced apoptosis. Moreover, TNFα reduced the levels of active Notch1 protein, which were partially restored by E2 treatment. Moreover, siRNA-mediated knockdown of estrogen receptor β (ERβ), but not ERα, abolished the effect of E2 on apoptosis. Additionally, the E2-mediated regulation of the levels of active Notch1 was abrogated after silencing ERβ. In summary, our results indicate that E2 requires active Notch1 through a mechanism involving ERβ to protect the endothelium in TNFα-induced inflammation. These findings could be relevant for assessing the efficacy and applicability of menopausal hormone treatment, because they may indicate that in women with impaired Notch signaling, hormone therapy might not effectively protect the endothelium.

Indexed as

ApoptosisSignal TransductionAmyloid Precursor Protein SecretasesCells, CulturedEndothelium, VascularEstradiolEstrogen Receptor alphaEstrogen Receptor betaHumansHuman Umbilical Vein Endothelial CellsPeptide FragmentsPhosphorylationProtease InhibitorsProtein Interaction Domains and MotifsProtein Kinase InhibitorsProtein Processing, Post-TranslationalAKT1 protein, humanAmyloid Precursor Protein SecretasesESR1 protein, humanESR2 protein, humanEstradiolEstrogen Receptor alphaEstrogen Receptor betaNOTCH1 protein, humanPeptide FragmentsProtease InhibitorsProtein Kinase InhibitorsProto-Oncogene Proteins c-aktReceptor, Notch1Recombinant ProteinsTNF protein, humanTumor Necrosis Factor-alphaAktapoptosisendothelial dysfunctionERβestrogenestrogen receptorNotch1Notch pathwaytumor necrosis factor (TNF)

Identifiers

PMID28893903
PMCPMC5672041
OpenAlexW2751669791

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.